MIF-Dependent Control of Tumor Immunity
Open Access
- 25 November 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
Abstract
Initially identified as a T lymphocyte-elicited inhibitor of macrophage motility, macrophage migration inhibitory factor (MIF) has since been found to be expressed by nearly every immune cell type examined and overexpressed in most solid and hematogenous malignant cancers. It is localized to both extracellular and intracellular compartments and physically interacts with more than a dozen different cell surface and intracellular proteins. Although classically associated with and characterized as a mediator of pro-inflammatory innate immune responses, more recent studies demonstrate that, in malignant disease settings, MIF contributes to anti-inflammatory, immune evasive, and immune tolerant phenotypes in both innate and adaptive immune cell types. This review will summarize the studies describing MIF in tumor-specific innate and adaptive immune responses and attempt to reconcile these various pleiotropic functions in normal physiology.Keywords
This publication has 199 references indexed in Scilit:
- Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74Cellular Signalling, 2011
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin LymphomaCell, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- TH17 cells in tumour immunity and immunotherapyNature Reviews Immunology, 2010
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor ImmunityImmunity, 2009
- Discovery of Human Macrophage Migration Inhibitory Factor (MIF)-CD74 Antagonists via Virtual ScreeningJournal of Medicinal Chemistry, 2008
- Macrophage Migration Inhibitory Factor Manipulation and Evaluation in Tumoral Hypoxic AdaptationMethods in Enzymology, 2007
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Inflammation and cancerNature, 2002